Pelargonium Graveolens Flower Oil

Pelargonium Graveolens Flower Oil and pregnancy

Caution Advised

• Hormone disruptor

Pelargonium graveolens flower oil (geranium oil) is an essential oil used primarily for fragrance in cosmetics. Essential oils are complex mixtures of volatile compounds, and geranium oil contains components like geraniol, citronellol, and linalool that can be absorbed through the skin. The safety of essential oils during pregnancy is debated among healthcare providers. Some aromatherapists and natural medicine practitioners caution against using geranium oil during pregnancy due to theoretical concerns about hormone-like effects and potential uterine stimulation, though these concerns are based primarily on traditional use warnings rather than clinical evidence. The National Association for Holistic Aromatherapy (NAHA) lists geranium oil as one that should be used cautiously during pregnancy. While no specific studies demonstrate harm from topical cosmetic use of geranium oil during pregnancy, the limited safety data and theoretical hormonal activity lead many obstetricians and dermatologists to recommend that pregnant women avoid or limit exposure to essential oils, particularly in the first trimester. Organizations like ACOG do not provide specific guidance on individual essential oils in cosmetics, but many pregnancy-focused dermatologists suggest that pregnant women who wish to be conservative should choose fragrance-free products or those scented with safer alternatives. The main concerns are the lack of robust safety testing during pregnancy and the bioactive nature of essential oil compounds. Women who experience sensitivity, develop skin reactions, or have concerns should discontinue use and consult their healthcare provider.

Pelargonium Graveolens Flower Oil and breastfeeding

Safe to Use

Geranium oil in cosmetics is used at low concentrations primarily for fragrance. When applied topically, small amounts of volatile compounds may be absorbed, though systemic absorption is limited and varies based on product type and application area. According to lactation resources and aromatherapy safety guidelines, topical use of geranium oil in cosmetic products is generally considered low-risk during breastfeeding when used in typical cosmetic concentrations. The compounds are not known to significantly transfer into breast milk when used topically on skin areas away from the breast. However, most lactation consultants recommend avoiding application of strongly scented products directly on breast tissue where babies nurse, as infants may reject breastfeeding due to unfamiliar scents or experience mild irritation from direct contact with residual essential oils. Breastfeeding mothers with sensitive skin or those whose infants show sensitivity should choose fragrance-free alternatives. The American Academy of Pediatrics (AAP) does not specifically address cosmetic essential oils but notes that minimizing infant exposure to unnecessary chemicals is prudent. Overall, occasional use of products containing geranium oil away from the breastfeeding area poses minimal risk.

Pelargonium Graveolens Flower Oil and postpartum

Safe to Use

• Irritant
• Common allergen

For postpartum women not breastfeeding, the primary concerns with geranium oil are the same as for the general population: potential for allergic reactions and skin irritation, particularly in individuals with sensitive skin or existing contact allergies to fragrance components. There are no specific postpartum health concerns related to topical use of geranium oil beyond the standard irritation and allergy risks. Women with hormone-sensitive conditions should be aware that some aromatherapy sources attribute weak hormone-like properties to geranium oil, though clinical evidence is limited. Those with known fragrance sensitivities or allergies to geraniol, citronellol, or linalool should avoid products containing this ingredient.

Pelargonium Graveolens Flower Oil and trying to conceive

Safe to Use

There is no clinical evidence that topical use of geranium oil in cosmetic products affects fertility, ovulation, or conception. While some aromatherapy traditions attribute hormone-like properties to geranium oil, scientific studies have not demonstrated reproductive effects from cosmetic topical application. Women trying to conceive can use products containing geranium oil without documented fertility concerns. However, since some healthcare providers recommend avoiding essential oils once pregnancy is confirmed due to limited safety data in early pregnancy, women with fertility concerns or those who prefer a conservative approach may choose to switch to fragrance-free alternatives during the trying-to-conceive period. This precautionary approach allows for seamless continuation if pregnancy occurs.

Pelargonium Graveolens Flower Oil and PCOS

Safe to Use

Pelargonium graveolens flower oil is primarily a fragrance ingredient with no documented effects on androgen levels, insulin function, or other metabolic pathways relevant to PCOS. While some aromatherapy sources claim hormone-balancing properties for geranium oil, there is no clinical evidence supporting significant hormonal effects from topical cosmetic use. Women with PCOS can generally use products containing geranium oil without concerns about hormonal interference or interactions with PCOS medications. The primary considerations are the same as for the general population: potential for skin irritation or allergic reactions, particularly in those with sensitive or reactive skin. Some women with PCOS experience increased skin sensitivity due to hormonal fluctuations or inflammatory processes, and may find essential oil fragrances irritating. Those with known fragrance allergies or sensitive skin may prefer fragrance-free alternatives.

Pelargonium Graveolens Flower Oil and general use

Safe to Use

• Common allergen
• Irritant

Pelargonium graveolens flower oil is recognized as a moderate-risk fragrance ingredient primarily due to its allergenic potential. The ingredient contains several components (geraniol, citronellol, linalool) that are known contact allergens and can cause allergic reactions in sensitized individuals. According to the SCCS and IFRA guidelines, geranium oil should be used at appropriate concentrations with proper labeling of allergenic components. The EU requires disclosure of these allergens on product labels to help consumers with known sensitivities make informed decisions. Contact dermatitis from geranium oil is relatively uncommon but does occur, with prevalence estimates ranging from 1-3% in patch testing studies. The ingredient can also cause irritation in people with sensitive skin, particularly at higher concentrations. Dermatologists generally consider geranium oil acceptable for use in fragranced cosmetic products for the general population, with the caveat that individuals with fragrance allergies, sensitive skin, or conditions like eczema or rosacea may want to choose fragrance-free alternatives. The ingredient has a long history of use in perfumery and cosmetics. Those with known allergies to fragrance components or who experience reactions should avoid products containing this ingredient.

Everything else flagged for the same profiles

• Flagged in pregnancy

Related ingredients

Ingredients that raise the same concerns.

• Parfum/FragranceHormone disruptor, Irritant, Common allergen
• Lavandula Angustifolia OilHormone disruptor, Irritant, Common allergen
• Rosmarinus Officinalis Leaf OilHormone disruptor, Irritant, Common allergen
• Arnica Montana Flower ExtractHormone disruptor, Irritant, Common allergen
• Lavandula Hybrida OilHormone disruptor, Irritant, Common allergen
• Illicium Verum Fruit ExtractHormone disruptor, Irritant, Common allergen

Where this came from

Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.

Assessment last pulled from the ingredient database on 15 September 2026.